#AUA14 - Poster: Reduction in urinary incontinence and improvement in quality of life with onabotulinumtoxinA in overactive bladder patients is unaffected by the use of clean intermittent catheterization or the presence of urinary tract infection

ORLANDO, FL USA (UroToday.com) - Presented by David Sussman,1 Jennifer Gruenenfelder,2 Heinrich Schulte-Baukloh,3 Steven Guard,4 Yan Zheng,5 and Karel Everaert6 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

aua 2014 MP76-05 sussman poster thumb

1Rowan University School of Osteopathic Medicine, Stratford, NJ, USA; 2Orange County Urology Associates, Laguna Hills, CA, USA; 3St. Hedwig-Krankenhaus, Berlin, Germany; 4Allergan, Ltd., Marlow, UK; 5Allergan, Inc., Bridgewater, NJ, USA; 6Ghent University Hospital, Gent, Belgium

 

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe